Acurx Pharmaceuticals, Inc.7月15日成交额为37.40万美元

市场透视2025-07-16

美东时间2025年7月15日，Acurx Pharmaceuticals, Inc.（ACXP.US）成交额为37.40万美元，成交额较昨日增加52.55%，当日成交量为85.11万股。Acurx Pharmaceuticals, Inc.（ACXP.US）于2025年7月15日跌4.91%，报0.434美元，该股过去5个交易日跌11.33%，年初至今跌46.73%，过去60日涨12.62%。|近...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2551191113?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-16 09:15","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2551191113","market":"us","top_or_hot":-1,"title":"Acurx Pharmaceuticals, Inc.7月15日成交额为37.40万美元","media":"市场透视","content":"<div>\n<p>美东时间2025年7月15日，Acurx Pharmaceuticals, Inc.（ACXP.US）成交额为37.40万美元，成交额较昨日增加52.55%，当日成交量为85.11万股。Acurx Pharmaceuticals, Inc.（ACXP.US）于2025年7月15日跌4.91%，报0.434美元，该股过去5个交易日跌11.33%，年初至今跌46.73%，过去60日涨12.62%。|近...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716091549a6ac2c48&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Acurx Pharmaceuticals, Inc.7月15日成交额为37.40万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAcurx Pharmaceuticals, Inc.7月15日成交额为37.40万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-16 09:15 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716091549a6ac2c48&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美东时间2025年7月15日，Acurx Pharmaceuticals, Inc.（ACXP.US）成交额为37.40万美元，成交额较昨日增加52.55%，当日成交量为85.11万股。Acurx Pharmaceuticals, Inc.（ACXP.US）于2025年7月15日跌4.91%，报0.434美元，该股过去5个交易日跌11.33%，年初至今跌46.73%，过去60日涨12.62%。|近...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716091549a6ac2c48&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ACXP","symbol_name":"Acurx Pharmaceuticals, LLC*","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716091549a6ac2c48&s=b","article_id":"2551191113","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716091549a6ac2c48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2551191113","pubTimestamp":1752628533,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"美东时间2025年7月15日，Acurx Pharmaceuticals, Inc.成交额为37.40万美元，成交额较昨日增加52.55%，当日成交量为85.11万股。Acurx Pharmaceuticals, Inc.于2025年7月15日跌4.91%，报0.434美元，该股过去5个交易日跌11.33%，年初至今跌46.73%，过去60日涨12.62%。该公司的方法是开发具有革兰氏阳性选择性谱的候选抗生素。该公司的部门包括开发临床和临床前候选产品，以开发公司的专有新疗法。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ACXP":"Acurx Pharmaceuticals, LLC*","BK4563":"昨日强势股","BK4539":"次新股","BK4139":"生物科技"},"translate_title":"Acurx Pharmaceuticals, Inc. turnover of $374K on July 15","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACXP":0.9},"content_text":"美东时间2025年7月15日，Acurx Pharmaceuticals, Inc.（ACXP.US）成交额为37.40万美元，成交额较昨日增加52.55%，当日成交量为85.11万股。Acurx Pharmaceuticals, Inc.（ACXP.US）于2025年7月15日跌4.91%，报0.434美元，该股过去5个交易日跌11.33%，年初至今跌46.73%，过去60日涨12.62%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-15|37.40万|52.55%|85.11万|#|2025-07-14|24.51万|26.72%|53.41万|#|2025-07-11|19.34万|-54.29%|40.40万|#|2025-07-10|42.32万|-53.61%|84.49万|#|2025-07-09|91.23万|123.69%|169.26万|Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。该公司的方法是开发具有革兰氏阳性选择性谱的候选抗生素。该公司的部门包括开发临床和临床前候选产品，以开发公司的专有新疗法。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2551191113","isCrawlerRequest":true}